Which manufacturer produces imported lorlatinib? How much does it cost?

Lorlatinib (Lorlatinib, also known as lorlatinib) is an important drug in the treatment of lung cancer. Its manufacturer is Pfizer Pharmaceuticals Co., Ltd. of the United States. As a third-generation new drug for the treatment of non-small cell lung cancer (NSCLC), this drug has significant efficacy, especially for patients with ALK-positive and ROS1-positive metastatic NSCLC, and it brings new treatment hope.

Pfizer Pharmaceutical Co., Ltd., as a world-renowned pharmaceutical company, has been committed to the research, development and production of innovative drugs. Lorlatinib, as its emerging product, has attracted much attention since its launch. Its unique dual receptor tyrosine kinase inhibitory effect makes it exhibit excellent results in the treatment of lung cancer.

Currently, the price of lorlatinib has become the focus of many patients. In my country, a box of lorlatinib's original drug usually costs thousands or even tens of thousands of yuan, which is expensive. But fortunately, my country's medical insurance policy provides certain support for patients. Patients can reduce their financial burden through medical insurance reimbursement. For specific reimbursement ratios and conditions, please consult the local medical insurance bureau.

In addition to original drugs, affordable generic versions are also sold overseas. Lucius Pharmaceuticals and Daxiong Pharmaceuticals in Laos are two relatively common brands, and their generic drugs have received government approval and are officially on the market. The price is much cheaper than the original drug, with a box costing about two to three thousand yuan. In addition, there are also generic versions of lorlatinib on the market such as the ASEAN version and the United Pharmaceuticals version. The price is also relatively low, with a box of about more than 3,000 yuan. These pharmaceutical companies enjoy a certain reputation and the quality of the generic drugs they produce is guaranteed.

In general, lorlatinib is a highly effective lung cancer treatment drug, and its manufacturer is Pfizer. In our country, its price is relatively high, but patients can reduce their financial burden through medical insurance reimbursement. At the same time, affordable generic versions are also sold overseas, providing patients with more choices. When choosing drugs, patients should choose according to their own financial situation and condition needs, and use drugs rationally under the guidance of a doctor.